Clinical Trials Logo

Crow's Feet Lines clinical trials

View clinical trials related to Crow's Feet Lines.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06376838 Completed - Crow's Feet Lines Clinical Trials

To Prove the Non-inferiority of DLMR01 by Evaluating the Injecting Efficacy and Safety DLMR01 and Control for Patients in Crow's Feet

dermal filler
Start date: July 7, 2020
Phase: N/A
Study type: Interventional

This clinical study is a confirmatory clinical study to prove that the test device, DLMR01, is non-inferior to the control device, Rejuran®, in terms of temporary wrinkle improvement effect on crow's feet and safety. After applying DLMR01, a test device, and Rejuran®, a control device, respectively to wrinkles around the eyes, randomization to compare and evaluate the temporary wrinkle improvement effect and safety of the two clinical study medical devices, subject-evaluator blinding, pair matching, It was designed as a comparative clinical study.

NCT ID: NCT03408236 Completed - Crow's Feet Lines Clinical Trials

Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's Feet Lines

Start date: January 17, 2018
Phase: Phase 3
Study type: Interventional

To determine the efficacy and safety of Botulax® in treatment of crow's feet line

NCT ID: NCT03317574 Completed - Crow's Feet Lines Clinical Trials

MEDITOXIN® in Treatment of Crow's Feet Line

Start date: August 17, 2017
Phase: Phase 3
Study type: Interventional

to determine the efficacy and safety of Meditoxin® in treatment of crow's feet line

NCT ID: NCT02248844 Completed - Clinical trials for Lateral Canthal Lines

Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea

Start date: September 26, 2014
Phase:
Study type: Observational

This is a postmarketing surveillance study in Korea to evaluate the safety and effectiveness of BOTOX® for lateral canthal lines (crow's feet lines) with or without simultaneous glabellar lines.

NCT ID: NCT02195687 Completed - Clinical trials for Lateral Canthal Lines

BOTOX® in the Treatment of Crow's Feet Lines in China

Start date: September 2014
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety and efficacy of BOTOX® (botulinum toxin Type A) compared with placebo in patients with moderate to severe crow's feet lines (lateral canthal lines).

NCT ID: NCT02176356 Completed - Glabellar Lines Clinical Trials

Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)

Start date: June 30, 2014
Phase: Phase 4
Study type: Interventional

A study to evaluate patient satisfaction, aesthetic and psychological impact of combined treatment with BOTOX® Cosmetic (onabotulinumtoxinA), JUVÉDERM® ULTRA XC, JUVÉDERM® ULTRA PLUS XC, JUVÉDERM® VOLUMA® XC, and LATISSE® (bimatoprost ophthalmic solution).

NCT ID: NCT01797094 Completed - Glabellar Lines Clinical Trials

BOTOX® in the Treatment of Upper Facial Lines in Japan

Start date: February 2013
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety and efficacy of BOTOX® (botulinum toxin Type A) for the treatment of upper facial lines (Crow's Feet Lines and Frown Lines).

NCT ID: NCT01797081 Completed - Crow's Feet Lines Clinical Trials

BOTOX® in the Treatment of Crow's Feet Lines in Japan

Start date: January 31, 2013
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety and efficacy of BOTOX® (botulinum toxin Type A) compared to placebo for the treatment of Crow's Feet Lines (Lateral Canthus Rhytides).

NCT ID: NCT01224015 Completed - Glabellar Lines Clinical Trials

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines

Start date: May 2011
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety and efficacy of botulinum toxin type A compared to placebo for the treatment of Crow's Feet Lines and Frown Lines (Facial Rhytides) for patients who successfully completed Study 191622-099.

NCT ID: NCT01189760 Completed - Glabellar Lines Clinical Trials

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines

Start date: September 1, 2010
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety and efficacy of botulinum toxin Type A compared to placebo for the treatment of Crow's Feet Lines and Frown Lines (Facial Rhytides)